Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 2.96
12.1 %
$ 9.13 M
Market Cap
-2.14
P/E
1. INTRINSIC VALUE
Balance Sheet
IM Cannabis Corp.
| Current Assets | 23.4 M |
| Cash & Short-Term Investments | 863 K |
| Receivables | 16.7 M |
| Other Current Assets | 5.82 M |
| Non-Current Assets | 15.8 M |
| Long-Term Investments | 1.63 M |
| PP&E | 4.18 M |
| Other Non-Current Assets | 10 M |
| Current Liabilities | 34.9 M |
| Accounts Payable | 11.2 M |
| Short-Term Debt | 17.4 M |
| Other Current Liabilities | 6.38 M |
| Non-Current Liabilities | 1.12 M |
| Long-Term Debt | 637 K |
| Other Non-Current Liabilities | 487 K |
EFFICIENCY
Earnings Waterfall
IM Cannabis Corp.
| Revenue | 54 M |
| Cost Of Revenue | 45.6 M |
| Gross Profit | 8.45 M |
| Operating Expenses | 18.7 M |
| Operating Income | -10.2 M |
| Other Expenses | 1.54 M |
| Net Income | -11.8 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
IM Cannabis Corp.
| Net Income | -11.8 M |
| Depreciation & Amortization | 2.18 M |
| Capital Expenditures | -156 K |
| Stock-Based Compensation | 369 K |
| Change in Working Capital | 2.48 M |
| Others | 472 K |
| Free Cash Flow | -1.23 M |
Wall Street Analysts Price Targets
IM Cannabis Corp.
IMCC has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
IMCC does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
IM Cannabis Corp.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
IM Cannabis Provides Corporate Updates
TORONTO and GLIL YAM, Israel , July 1, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced the following corproate updates. As previously reported on April 11, 2025, the Company received a deficiency letter (the "Nasdaq Letter") on April 9, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (the "Nasdaq") notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market (the "Stockholders' Equity Requirement"), nor is it in compliance with either of the alternative listing standards, market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years.
prnewswire.com
- 2 weeks ago
CSE Bulletin: Delist - IM Cannabis Corp. (IMCC)
Toronto, Ontario--(Newsfile Corp. - Le 28 mai/May 2025) - The common shares of IM Cannabis Corp. (the "Issuer") will be delisted from the CSE at market close, June 2, 2025. The Issuer will continue to trade on Nasdaq.
newsfilecorp.com
- 1 month ago
IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
TORONTO and GLIL YAM, Israel , May 28, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has applied for a voluntary delisting of its common shares ("Shares") from the Canadian Securities Exchange (the "CSE"). The delisting from the CSE will not affect the Company's listing on NASDAQ and its Shares will continue trading on the NASDAQ under the symbol "IMCC".
prnewswire.com
- 1 month ago
IM Cannabis Provides Corporate Updates
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO and GLIL YAM, Israel, May 27, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the following corporate updates. Meeting Results Further to its press releases dated Aprill 11, 2025 (the " April 11 Release") and May 7, 2025 (the " May 7 Release"), the Company is pleased to announce results of its annual general and special meeting, held on Friday, May 23, 2025 (the "Meeting").
prnewswire.com
- 1 month ago
IM Cannabis Corp. (IMCC) Q1 2025 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC ) Q1 2025 Earnings Call May 15, 2025 9:00 AM ET Company Participants Anna Taranko - Director, Investor and Public Relations Oren Shuster - Chief Executive Officer Uri Birenberg - Chief Financial Officer Operator Good morning, and welcome to IM Cannabis' First Quarter 2025 Earnings Conference Call. Today's conference call is being recorded.
seekingalpha.com
- 2 months ago
IM Cannabis Reports First Quarter Financial Results
IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress TORONTO and GLIL YAM, Israel , May 15, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2025. All amounts are reported in Canadian dollars and compared to the quarter ended March 31, 2024, unless otherwise stated.
prnewswire.com
- 2 months ago
IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction
TORONTO and GLIL YAM, Israel , May 7, 2025 /PRNewswire/ -- IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further its news release dated April 11, 2025 (the " April 11 Release"), it has filed a management information circular (the "Circular") in connection with the upcoming annual general and special meeting of the shareholders of the Company ("Shareholders") to be held on May 23, 2025 (the "Meeting"). Capitalized terms not otherwise defined herein have the meanings attributed to them in the April 11 Release.
prnewswire.com
- 2 months ago
IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET
TORONTO and GLIL YAM, Israel , May 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens. The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community.
prnewswire.com
- 2 months ago
IM Cannabis Provides Corporate Updates
TORONTO and GLIL YAM, Israel , April 11, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced the following corporate updates. Nasdaq Notification Letter The Company has received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") dated April 9, 2025, notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1).
prnewswire.com
- 3 months ago
IM Cannabis Corp. (IMCC) Q4 2024 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC ) Q4 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chairman and Chief Executive Officer Uri Birenberg - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Operator Good morning and welcome to IM Cannabis' Fourth Quarter and Full Year 2024 Earnings Conference Call. Today's conference call is being recorded.
seekingalpha.com
- 3 months ago
IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results
Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit TORONTO and GLIL YAM, Israel , March 31, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce its financial results for the fourth quarter and year ended December 31, 2024. Unless otherwise stated, all amounts are reported in Canadian dollars and are compared to the quarter ended December 31, 2023.
prnewswire.com
- 3 months ago
IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET
TORONTO and GLIL YAM, Israel , March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2024 ended December 31, 2024, on Monday, March 31, 2025 before the market opens. The Company will host a zoom web conference on the same day at 9:00a.m.
prnewswire.com
- 3 months ago
8. Profile
Summary
IM Cannabis Corp. IMCC
COUNTRY
IL
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 9.13 M
Dividend Yield
0.00%
Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Contact
Kibbutz Glil Yam, Tel Aviv, 4690500
https://www.imcannabis.com
IPO
Date
May 20, 2020
Employees
95
Officers
Advocate Michal Lebovitz Nissimov
General Counsel & Secretary
Mr. Oren Shuster
Executive Chairman & Chief Executive Officer
Mr. Richard Balla
Chief Executive Officer of Adjupharm
Mr. Eyal Fisher
Chief Executive Officer of the IMC Holdings
Anna Taranko
Director Investor & Public Relations
Mr. Uri Birenberg
Chief Financial Officer